首页 › 基金 › Euro Pacific Asset Management, LLC › GSK

Euro Pacific Asset Management, LLC 对 GSK 的持仓历史

GSK PLC ADR F · 医疗保健

Euro Pacific Asset Management, LLC 在 Q3 2026 的 13F 申报中披露持有 GSK(GSK PLC ADR F)204,907 股,市值约 US$10.3M,约占其申报组合的 0.84%,在其申报持仓中市值排名第 31 位。 Euro Pacific Asset Management, LLC 最近 13 个申报季度中有 13 个季度披露了 GSK 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)204.91K 股
申报持仓市值$10.32M
组合权重0.84%
首次申报Q3 2023
最近变动减持
更新于2026-10-14

最后更新: 2026-10-14 · 来源: SEC EDGAR Form 13F-HR

Euro Pacific Asset Management, LLC 对 GSK 的持仓演变

Euro Pacific Asset Management, LLC 于 Q3 2023 首次披露 GSK 持仓:232,046 股(约 US$8.4M)。 该持仓在 Q3 2026 达到峰值 204,907 股,市值约 US$10.3M。 在 13 次申报中,Euro Pacific Asset Management, LLC 1 次增持、10 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 204,907 股、市值约 US$10.3M,环比减持 -1,727 股。。

逐季持仓明细

季度股数金额变化
Q3 2023 232.05K $8.43M 新进
Q4 2023 234.12K $8.74M 增持
Q1 2024 227.79K $9.58M 减持
Q2 2024 221.22K $8.55M 减持
Q3 2024 217.89K $8.88M 减持
Q4 2024 214.16K $7.22M 减持
Q1 2025 212.97K $8.23M 减持
Q2 2025 213.26K $8.20M 持有
Q3 2025 212.02K $8.74M 减持
Q4 2025 210.81K $9.44M 减持
Q1 2026 208.25K $10.10M 减持
Q2 2026 206.63K $6.59M 减持
Q3 2026 204.91K $10.32M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 GSK 与 13F 数据

GSK(GSK PLC ADR F)属于医疗保健行业。我们追踪的基金中还有 23 只申报持有 GSK,申报仓位最大的包括:Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 GSK 的基金

查看 GSK 的全部基金持有人 →

常见问题

How long has Euro Pacific Asset Management, LLC held GSK?

Euro Pacific Asset Management, LLC has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Euro Pacific Asset Management, LLC's current position in GSK?

As of Q3 2026, Euro Pacific Asset Management, LLC holds 204.91K shares of GSK (GSK PLC ADR F), valued at $10.32M, representing 0.84% of its reported portfolio and ranking #31.

Has Euro Pacific Asset Management, LLC been buying or selling GSK?

In the latest 13F filing (Q3 2026), Euro Pacific Asset Management, LLC reduced its position in GSK. The position peaked in Q3 2026 at 204.91K shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.